LOW-VOLUME · HOSP-HEAVY
isavuconazonium Side Effects
isavuconazonium (also sold as Cresemba) is a LOW-VOLUME FAERS extract #426 of 524 by FAERS report count. Still opens on HOSP-HEAVY: 32.1% mention hospitalization (1,032 reports).
Data updated 2026-05-15
- 3,219
- FAERS reports
Thinner FAERS book - still a temporal association ledger, not proof of cause. Methodology.
isavuconazonium: 32.1% mention hospitalization (1,032 reports). Death stamp DEATH-HEAVY; volume band LOW-VOLUME #426 of 524 by FAERS report count.
Thinner FAERS extract for isavuconazonium (Cresemba) (3,219 reports #426 of 524 by FAERS report count). 32.1% mention hospitalization (1,032 reports). Sparse books still carry named reaction rows when present; not medical advice.
Counts from the openFDA FAERS extract (2015–2025). Stamps SIGNAL · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
DEATH leads 310 of 3,219 reports
Who reports · age peak 45-64 (SEX-BALANCED)
Sex coding · SEX-BALANCED
Age peak 45-64 (634 reports)
FAERS filings rising toward 2025
Reactions in Death Reports
Death-mentioned subset is HEAVY here (674 reports, 20.9%). Top co-reported reactions in that subset - voluntary, not causal.
| Reaction | Reports |
|---|---|
| DEATH | 310 |
| ACUTE MYELOID LEUKAEMIA | 33 |
| SEPTIC SHOCK | 33 |
| CONDITION AGGRAVATED | 32 |
| ACUTE KIDNEY INJURY | 31 |
| MULTIPLE ORGAN DYSFUNCTION SYNDROME | 31 |
| ASPERGILLUS INFECTION | 25 |
| RESPIRATORY FAILURE | 25 |
| DISEASE PROGRESSION | 23 |
| SEPSIS | 23 |
| FEBRILE NEUTROPENIA | 20 |
| PNEUMONIA | 20 |
| BRONCHOPULMONARY ASPERGILLOSIS | 19 |
| COVID-19 | 17 |
| BLOOD ALKALINE PHOSPHATASE INCREASED | 14 |
| DYSPNOEA | 14 |
| HYPOTENSION | 14 |
| BLOOD BILIRUBIN INCREASED | 13 |
Reactions in Hospitalization Reports
Hospitalization is HEAVY (1,032, 32.1% of the book). Top reactions in those rows:
| Reaction | Reports |
|---|---|
| PNEUMONIA | 90 |
| FEBRILE NEUTROPENIA | 89 |
| PYREXIA | 86 |
| NAUSEA | 62 |
| DYSPNOEA | 55 |
| ACUTE KIDNEY INJURY | 53 |
| DIARRHOEA | 50 |
| DRUG INTERACTION | 49 |
| SEPSIS | 45 |
| VOMITING | 45 |
| DEATH | 44 |
| FATIGUE | 44 |
| HOSPITALISATION | 42 |
| PLATELET COUNT DECREASED | 38 |
| CONDITION AGGRAVATED | 33 |
| INFECTION | 32 |
| COVID-19 | 29 |
| HAEMOGLOBIN DECREASED | 27 |
How to read isavuconazonium FAERS figures (SIGNAL · DEATH-HEAVY · HOSP-HEAVY)
FAERS holds 3,219 voluntary reports linked to isavuconazonium (Cresemba), 2015-2025. Death is listed on 674 (20.9%). Hospitalization appears on 1,032 (32.1%). Top co-reported indication: Product Used For Unknown Indication.
Sparse extract - named reactions and SEX-BALANCED skew still differ by drug; not a complete safety profile.
Read with isavuconazonium
Peers ranked by ABS(total_reports), then an ABS(death_share) pole; guide hop follows DEATH-HEAVY · HOSP-HEAVY stamps.
ABS(total_reports) peer at 3,228 FAERS cases (Δ 9 heavier vs isavuconazonium); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's SIGNAL · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
ABS(total_reports) peer at 3,245 FAERS cases (Δ 26 heavier vs isavuconazonium); DEATH-HEAVY · HOSP-MID · SEX-BALANCED vs this page's SIGNAL · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
ABS(total_reports) peer at 3,267 FAERS cases (Δ 48 heavier vs isavuconazonium); DEATH-HEAVY · HOSP-MID · FEMALE-LED vs this page's SIGNAL · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
ABS(total_reports) peer at 3,268 FAERS cases (Δ 49 heavier vs isavuconazonium); DEATH-HEAVY · HOSP-MID · FEMALE-LED vs this page's SIGNAL · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
ABS(death_share) pole at 62.1% death-mentioned reports (Δ 41.2 pp vs isavuconazonium's DEATH-HEAVY): CASELOAD · HOSP-MID.
isavuconazonium stamps DEATH-HEAVY · HOSP-HEAVY; FAERS outcome shares are signal-detection rates, not incidence. Read them next to caseload SIGNAL and the label guide.